Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000929638-24-000646
Filing Date
2024-02-14
Accepted
2024-02-14 15:03:45
Documents
1
Group Members
BIHUA CHENCORMORANT ASSET MANAGEMENT, LPCORMORANT GLOBAL HEALTHCARE GP, LLCCORMORANT GLOBAL HEALTHCARE MASTER FUND, LPCORMORANT PRIVATE HEALTHCARE FUND II, LPCORMORANT PRIVATE HEALTHCARE GP II, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 schedule13ga.htm SC 13G/A 109084
  Complete submission text file 0000929638-24-000646.txt   111235
Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 857-702-0388
Cormorant Asset Management, LP (Filed by) CIK: 0001583977 (see all company filings)

EIN.: 462108927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address ONE KENDALL SQUARE. BUILDING 600-700 SUITE 6-401 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE. BUILDING 600-700 SUITE 6-401 CAMBRIDGE MA 02139 617-468-1900
Korro Bio, Inc. (Subject) CIK: 0001703647 (see all company filings)

EIN.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91158 | Film No.: 24636528
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)